ERAS

NASD Erasca, Inc.
Oct 1, 2026 · 9:52 AM ET DELAYED Market Open

$14.52 ↓ -0.14 (-0.95%) Trading Down from the previous close of $14.66, $0.22 below the day’s high of $14.74

YTD change
+290.32%
vs 20-day SMA
-5.38%
vs 200-day SMA
+4.69%

Price ranges

Previous day
$14.11 $15.12
open $14.37 close $14.66
+$0.29 (+2.02%)
Today
$14.44 $14.74
open $14.62 now $14.52
-$0.10 (-0.68%)
Past week
$13.54 $15.12
from $13.95 now $14.52
+$0.57 (+4.12%)
Past month
$13.54 $17.45
from $16.76 now $14.52
-$2.24 (-13.37%)
This year
$3.36 $24.28
from $3.72 now $14.52
+$10.80 (+290.32%)

Price & Performance

-1.94 (-11.69%) / 6M

$8.04$13.21$18.37$23.54Apr 1Jul 1Sep 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 40.7% away from all-time highs of $24.47
  • ERAS is up 290% since the beginning of the year
  • ERAS is up 557% over the past 12 months
  • ERAS is down 13% over the past 1 month
  • 11% of all ERAS investors are betting against ERAS

ERAS reads neutral: price sits above one of the two key moving averages, the 12-month move is +563.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.14
Earnings momentum -7.6% Quarterly EPS growth
Quarterly change -7.6%

Valuation

P/E ratio N/A
Enterprise value $4.3B
Beta -0.61

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$268.7M
Debt$44.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.1B

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $421.51 -0.50%
MRNA Moderna, Inc. $192.57 -5.35%
RVMD Revolution Medicines, Inc. $205.26 +0.38%
ROIV Roivant Sciences Ltd. $36.57 +0.19%
BNTX BioNTech SE Sponsored ADR $98.30 -0.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.